At least a_pump but this1 _may_ have another_gear.
After some consideration: the 100 billion, JHU clinical studies,
the looking-current paperwork, and the people who
are now surrounding this project (a mix of some fairly
knowledgeable people in their respective fields, some of whom
_do_ seem to have mixed reputations, but not necessarily looking for
white horses), the tech, and so on, I am cautiously optimistic here.
That is, it's just become too broad and too involving of many people who
MIGHT be interested in bilking their grandmothers, but it's not likely
and they're too old and wealthy to make that a plan for their respective
remaining lifespans. Instead, this looked big enough to hitch their
"apex" years being involved with, and that's what it's all eventually
about: Time, (and money) right? It's just not likely and too
superficial, that many decades on. Further, the
timeline with the posted 10-Q is pretty solid: The monstrous if of
nearing a stage of sending a product to market, late 2018, mentioned in
the ihub blurb above, may be more than idle backroom murmuring. This
update would all have to be done before a news release about the last
few years, especially if this has some news that really makes the
argument for another gear (the confidential info protected by the SEC
comes to my mind). And that's all been done, it appears. idk but some
speculation.
The defaulting weighs a _bit_ but not enough to to make this product
possibility not worth a starter pack o shares imo. That much incoming
debt burn is not sustainable but I think they are close, and imo Groman
wouldn't dump hunks of spa fortune into a bottomless hole. This burst
just may have put them over the top on the research end. It feels better
than a Tanzanian lithium mine ha.
VNTH a bit more confidently,
glta Monday...
SD
